Orange Book product · Generic (ANDA)
CELECOXIB
CELECOXIB
At a glance
Feb 01, 2016
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 01, 2016
10 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
CELECOXIB
Strength
50MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 206827
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CELECOXIB
- 2025VYSCOXABrand (NDA)
NDA 211759 · CARWIN PHARM ASSOC
- 2020ELYXYBBrand (NDA)
NDA 212157 · SCILEX PHARMS
- 2006CELEBREXBrand (NDA)
NDA 020998 · UPJOHN
- 2025CELECOXIBGeneric (ANDA)
ANDA 205938 · ZYDUS PHARMS
- 2025CELECOXIBGeneric (ANDA)
ANDA 213127 · STRIDES PHARMA
- 2023CELECOXIBGeneric (ANDA)
ANDA 212564 · YABAO PHARM
- 2021CELECOXIBGeneric (ANDA)
ANDA 213301 · UNICHEM
- 2020CELECOXIBGeneric (ANDA)
ANDA 212925 · PANGEA
- 2020CELECOXIBGeneric (ANDA)
ANDA 205129 · SCIEGEN PHARMS
- 2020CELECOXIBGeneric (ANDA)
ANDA 213598 · NANJING
- 2020CELECOXIBGeneric (ANDA)
ANDA 211412 · YILING
- 2020CELECOXIBGeneric (ANDA)
ANDA 207872 · TIANJIN TIANYAO
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
